Promising data in adult patients supports advancement into pediatric patientsData from this portion of the clinical program will inform pivotal studySAN CARLOS, Calif.--(BUSINESS WIRE)--#CDG--Glycomine, Inc., a clinical-stage biotechnology company focused on developing new therapies for orphan diseases, announced th...